The global meningococcal vaccines market is expected to reach USD 5.07 billion by 2030, at a CAGR of 6.5% during the forecast period 2021 to 2030. The meningococcal vaccine market has grown due to the increasing prevalence of meningitis disease. In addition, growing awareness about the disease, increasing R&D, and rising immunization programs are helping in market growth.